rethinkMushrooms Search
Menu
RethinkMushrooms

Psilocybin FDA Approval & Regulatory Path

Explore mushroom research and guides on psilocybin fda approval & regulatory path.

Psilocybin FDA Approval & Regulatory Path

Psilocybin's Path to FDA Approval: Where Things Stand

Psilocybin FDA approval status: not yet approved, but two successful Phase 3 trials (June 2025 and February 2026) put an NDA submission on track for late 2026 and an FDA decision in 2027.